nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenindamine—Oxcarbazepine—epilepsy syndrome	0.58	1	CrCtD
Phenindamine—Epinastine—Carbamazepine—epilepsy syndrome	0.0441	0.109	CrCrCtD
Phenindamine—Epinastine—Oxcarbazepine—epilepsy syndrome	0.0406	0.101	CrCrCtD
Phenindamine—Phenindione—Fosphenytoin—epilepsy syndrome	0.033	0.0819	CrCrCtD
Phenindamine—Cyproheptadine—Carbamazepine—epilepsy syndrome	0.0297	0.0737	CrCrCtD
Phenindamine—Mianserin—Oxcarbazepine—epilepsy syndrome	0.0274	0.0679	CrCrCtD
Phenindamine—Nortriptyline—Oxcarbazepine—epilepsy syndrome	0.0233	0.0579	CrCrCtD
Phenindamine—Phenindione—Phenytoin—epilepsy syndrome	0.0226	0.0561	CrCrCtD
Phenindamine—Oxcarbazepine—Carbamazepine—epilepsy syndrome	0.0215	0.0533	CrCrCtD
Phenindamine—Phenindione—Carbamazepine—epilepsy syndrome	0.0209	0.0518	CrCrCtD
Phenindamine—Phenindione—Oxcarbazepine—epilepsy syndrome	0.0192	0.0477	CrCrCtD
Phenindamine—Oxcarbazepine—Clobazam—epilepsy syndrome	0.019	0.0471	CrCrCtD
Phenindamine—Phenindione—Clobazam—epilepsy syndrome	0.0184	0.0457	CrCrCtD
Phenindamine—Chlorcyclizine—Clobazam—epilepsy syndrome	0.0179	0.0445	CrCrCtD
Phenindamine—Amitriptyline—Oxcarbazepine—epilepsy syndrome	0.0177	0.044	CrCrCtD
Phenindamine—Oxcarbazepine—Diazepam—epilepsy syndrome	0.0177	0.0438	CrCrCtD
Phenindamine—Methdilazine—Carbamazepine—epilepsy syndrome	0.0157	0.0389	CrCrCtD
Phenindamine—Methdilazine—Oxcarbazepine—epilepsy syndrome	0.0145	0.0359	CrCrCtD
Phenindamine—Mirtazapine—HRH3—epilepsy syndrome	0.000179	0.0514	CrCbGaD
Phenindamine—Amitriptyline—KCND2—epilepsy syndrome	0.000177	0.0511	CrCbGaD
Phenindamine—Amitriptyline—KCNQ2—epilepsy syndrome	0.000165	0.0475	CrCbGaD
Phenindamine—Amitriptyline—KCNQ3—epilepsy syndrome	0.000165	0.0475	CrCbGaD
Phenindamine—Amitriptyline—NTRK2—epilepsy syndrome	0.00014	0.0404	CrCbGaD
Phenindamine—Metixene—CHRM3—epilepsy syndrome	0.000137	0.0394	CrCbGaD
Phenindamine—Metixene—CHRM1—epilepsy syndrome	0.000128	0.0368	CrCbGaD
Phenindamine—Benzatropine—CHRM1—epilepsy syndrome	0.000118	0.0339	CrCbGaD
Phenindamine—Metixene—CHRM2—epilepsy syndrome	0.000104	0.03	CrCbGaD
Phenindamine—Cyproheptadine—CHRM3—epilepsy syndrome	0.000104	0.0299	CrCbGaD
Phenindamine—Epinastine—HTR7—epilepsy syndrome	0.000103	0.0297	CrCbGaD
Phenindamine—Cyproheptadine—CHRM1—epilepsy syndrome	9.67e-05	0.0279	CrCbGaD
Phenindamine—Benzatropine—CHRM2—epilepsy syndrome	9.62e-05	0.0277	CrCbGaD
Phenindamine—Epinastine—ADRA2A—epilepsy syndrome	8.83e-05	0.0254	CrCbGaD
Phenindamine—Mirtazapine—HTR7—epilepsy syndrome	8.1e-05	0.0234	CrCbGaD
Phenindamine—Cyproheptadine—CHRM2—epilepsy syndrome	7.9e-05	0.0228	CrCbGaD
Phenindamine—Nortriptyline—CHRM3—epilepsy syndrome	7.02e-05	0.0202	CrCbGaD
Phenindamine—Mirtazapine—ADRA2A—epilepsy syndrome	6.95e-05	0.02	CrCbGaD
Phenindamine—Nortriptyline—CHRM1—epilepsy syndrome	6.55e-05	0.0189	CrCbGaD
Phenindamine—Mianserin—HTR7—epilepsy syndrome	5.96e-05	0.0172	CrCbGaD
Phenindamine—Benzatropine—CYP2C19—epilepsy syndrome	5.93e-05	0.0171	CrCbGaD
Phenindamine—Oxcarbazepine—CYP2C19—epilepsy syndrome	5.88e-05	0.017	CrCbGaD
Phenindamine—Amitriptyline—OPRD1—epilepsy syndrome	5.73e-05	0.0165	CrCbGaD
Phenindamine—Nortriptyline—CHRM2—epilepsy syndrome	5.35e-05	0.0154	CrCbGaD
Phenindamine—Mirtazapine—SLC6A4—epilepsy syndrome	5.3e-05	0.0153	CrCbGaD
Phenindamine—Epinastine—HTR2A—epilepsy syndrome	5.18e-05	0.0149	CrCbGaD
Phenindamine—Mianserin—ADRA2A—epilepsy syndrome	5.11e-05	0.0147	CrCbGaD
Phenindamine—Amitriptyline—CHRM3—epilepsy syndrome	4.87e-05	0.014	CrCbGaD
Phenindamine—Epinastine—CYP2D6—epilepsy syndrome	4.73e-05	0.0136	CrCbGaD
Phenindamine—Amitriptyline—CHRM1—epilepsy syndrome	4.55e-05	0.0131	CrCbGaD
Phenindamine—Benzatropine—CYP2D6—epilepsy syndrome	4.4e-05	0.0127	CrCbGaD
Phenindamine—Amitriptyline—OPRM1—epilepsy syndrome	4.39e-05	0.0126	CrCbGaD
Phenindamine—Mirtazapine—HTR2A—epilepsy syndrome	4.07e-05	0.0117	CrCbGaD
Phenindamine—Cyproheptadine—HTR2A—epilepsy syndrome	3.95e-05	0.0114	CrCbGaD
Phenindamine—Mianserin—SLC6A4—epilepsy syndrome	3.9e-05	0.0112	CrCbGaD
Phenindamine—Mirtazapine—CYP2D6—epilepsy syndrome	3.73e-05	0.0107	CrCbGaD
Phenindamine—Amitriptyline—CHRM2—epilepsy syndrome	3.71e-05	0.0107	CrCbGaD
Phenindamine—Amitriptyline—HTR7—epilepsy syndrome	3.69e-05	0.0106	CrCbGaD
Phenindamine—HRH1—GPCR ligand binding—GRM5—epilepsy syndrome	3.63e-05	0.00267	CbGpPWpGaD
Phenindamine—HRH1—GPCRs, Class A Rhodopsin-like—BDKRB2—epilepsy syndrome	3.62e-05	0.00267	CbGpPWpGaD
Phenindamine—HRH1—Signaling by GPCR—ACKR4—epilepsy syndrome	3.59e-05	0.00264	CbGpPWpGaD
Phenindamine—HRH1—GPCR downstream signaling—SSTR4—epilepsy syndrome	3.57e-05	0.00263	CbGpPWpGaD
Phenindamine—HRH1—GPCR downstream signaling—SSTR5—epilepsy syndrome	3.57e-05	0.00263	CbGpPWpGaD
Phenindamine—HRH1—GPCRs, Class A Rhodopsin-like—CNR1—epilepsy syndrome	3.56e-05	0.00262	CbGpPWpGaD
Phenindamine—Nortriptyline—SLC6A4—epilepsy syndrome	3.48e-05	0.01	CrCbGaD
Phenindamine—HRH1—GPCR ligand binding—CX3CR1—epilepsy syndrome	3.48e-05	0.00256	CbGpPWpGaD
Phenindamine—HRH1—GPCRs, Class A Rhodopsin-like—HTR7—epilepsy syndrome	3.47e-05	0.00255	CbGpPWpGaD
Phenindamine—HRH1—GPCR downstream signaling—CCR10—epilepsy syndrome	3.42e-05	0.00252	CbGpPWpGaD
Phenindamine—HRH1—GPCR ligand binding—CX3CL1—epilepsy syndrome	3.41e-05	0.00251	CbGpPWpGaD
Phenindamine—HRH1—GPCR ligand binding—BDKRB1—epilepsy syndrome	3.41e-05	0.00251	CbGpPWpGaD
Phenindamine—HRH1—GPCR ligand binding—CHRM2—epilepsy syndrome	3.41e-05	0.00251	CbGpPWpGaD
Phenindamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—epilepsy syndrome	3.38e-05	0.00249	CbGpPWpGaD
Phenindamine—Epinastine—ABCB1—epilepsy syndrome	3.38e-05	0.00974	CrCbGaD
Phenindamine—HRH1—GPCR ligand binding—GABBR1—epilepsy syndrome	3.32e-05	0.00244	CbGpPWpGaD
Phenindamine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR2—epilepsy syndrome	3.3e-05	0.00243	CbGpPWpGaD
Phenindamine—HRH1—Class A/1 (Rhodopsin-like receptors)—SST—epilepsy syndrome	3.3e-05	0.00243	CbGpPWpGaD
Phenindamine—Nortriptyline—CYP2C19—epilepsy syndrome	3.3e-05	0.00951	CrCbGaD
Phenindamine—Oxcarbazepine—ALB—epilepsy syndrome	3.26e-05	0.0094	CrCbGaD
Phenindamine—HRH1—Signaling by GPCR—SSTR4—epilepsy syndrome	3.24e-05	0.00239	CbGpPWpGaD
Phenindamine—HRH1—Signaling by GPCR—SSTR5—epilepsy syndrome	3.24e-05	0.00239	CbGpPWpGaD
Phenindamine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—epilepsy syndrome	3.23e-05	0.00238	CbGpPWpGaD
Phenindamine—HRH1—GPCR ligand binding—HRH3—epilepsy syndrome	3.18e-05	0.00234	CbGpPWpGaD
Phenindamine—Amitriptyline—ADRA2A—epilepsy syndrome	3.17e-05	0.00913	CrCbGaD
Phenindamine—HRH1—G alpha (q) signalling events—HTR2A—epilepsy syndrome	3.15e-05	0.00231	CbGpPWpGaD
Phenindamine—HRH1—GPCR ligand binding—OPRM1—epilepsy syndrome	3.13e-05	0.0023	CbGpPWpGaD
Phenindamine—HRH1—Signaling by GPCR—CCR10—epilepsy syndrome	3.11e-05	0.00229	CbGpPWpGaD
Phenindamine—HRH1—Class A/1 (Rhodopsin-like receptors)—BDKRB2—epilepsy syndrome	3.11e-05	0.00228	CbGpPWpGaD
Phenindamine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL12—epilepsy syndrome	3.11e-05	0.00228	CbGpPWpGaD
Phenindamine—HRH1—Class A/1 (Rhodopsin-like receptors)—CNR1—epilepsy syndrome	3.05e-05	0.00224	CbGpPWpGaD
Phenindamine—Mianserin—HTR2A—epilepsy syndrome	2.99e-05	0.00863	CrCbGaD
Phenindamine—HRH1—GPCR downstream signaling—GRM2—epilepsy syndrome	2.99e-05	0.0022	CbGpPWpGaD
Phenindamine—HRH1—G alpha (q) signalling events—AGT—epilepsy syndrome	2.98e-05	0.0022	CbGpPWpGaD
Phenindamine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR7—epilepsy syndrome	2.97e-05	0.00219	CbGpPWpGaD
Phenindamine—HRH1—GPCR ligand binding—CCR3—epilepsy syndrome	2.96e-05	0.00218	CbGpPWpGaD
Phenindamine—HRH1—GPCR ligand binding—NPY—epilepsy syndrome	2.88e-05	0.00212	CbGpPWpGaD
Phenindamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—epilepsy syndrome	2.81e-05	0.00207	CbGpPWpGaD
Phenindamine—HRH1—GPCR ligand binding—OXT—epilepsy syndrome	2.78e-05	0.00205	CbGpPWpGaD
Phenindamine—HRH1—GPCR ligand binding—CRH—epilepsy syndrome	2.78e-05	0.00205	CbGpPWpGaD
Phenindamine—HRH1—GPCR ligand binding—CCL3—epilepsy syndrome	2.78e-05	0.00205	CbGpPWpGaD
Phenindamine—HRH1—GPCR ligand binding—CXCL2—epilepsy syndrome	2.78e-05	0.00205	CbGpPWpGaD
Phenindamine—Mianserin—CYP2D6—epilepsy syndrome	2.74e-05	0.00789	CrCbGaD
Phenindamine—HRH1—IL-4 Signaling Pathway—AKT1—epilepsy syndrome	2.72e-05	0.002	CbGpPWpGaD
Phenindamine—HRH1—Signaling by GPCR—GRM2—epilepsy syndrome	2.72e-05	0.002	CbGpPWpGaD
Phenindamine—HRH1—GPCR downstream signaling—SSTR3—epilepsy syndrome	2.71e-05	0.00199	CbGpPWpGaD
Phenindamine—Nortriptyline—HTR2A—epilepsy syndrome	2.68e-05	0.00771	CrCbGaD
Phenindamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—epilepsy syndrome	2.67e-05	0.00196	CbGpPWpGaD
Phenindamine—HRH1—GPCR downstream signaling—CCR9—epilepsy syndrome	2.59e-05	0.00191	CbGpPWpGaD
Phenindamine—HRH1—GPCR downstream signaling—NPY2R—epilepsy syndrome	2.59e-05	0.00191	CbGpPWpGaD
Phenindamine—HRH1—GPCR downstream signaling—CCR8—epilepsy syndrome	2.59e-05	0.00191	CbGpPWpGaD
Phenindamine—HRH1—GPCR downstream signaling—ARHGEF9—epilepsy syndrome	2.59e-05	0.00191	CbGpPWpGaD
Phenindamine—HRH1—GPCR downstream signaling—SSTR1—epilepsy syndrome	2.59e-05	0.00191	CbGpPWpGaD
Phenindamine—HRH1—GPCR downstream signaling—GRM4—epilepsy syndrome	2.54e-05	0.00187	CbGpPWpGaD
Phenindamine—HRH1—GPCR downstream signaling—GRM3—epilepsy syndrome	2.54e-05	0.00187	CbGpPWpGaD
Phenindamine—HRH1—GPCR ligand binding—SST—epilepsy syndrome	2.52e-05	0.00185	CbGpPWpGaD
Phenindamine—HRH1—GPCR ligand binding—CCR2—epilepsy syndrome	2.52e-05	0.00185	CbGpPWpGaD
Phenindamine—HRH1—Class A/1 (Rhodopsin-like receptors)—AVP—epilepsy syndrome	2.5e-05	0.00184	CbGpPWpGaD
Phenindamine—HRH1—GPCR downstream signaling—SSTR2—epilepsy syndrome	2.5e-05	0.00184	CbGpPWpGaD
Phenindamine—HRH1—GPCRs, Class A Rhodopsin-like—CCR5—epilepsy syndrome	2.48e-05	0.00183	CbGpPWpGaD
Phenindamine—HRH1—GPCR ligand binding—ADRA2A—epilepsy syndrome	2.46e-05	0.00181	CbGpPWpGaD
Phenindamine—HRH1—Signaling by GPCR—SSTR3—epilepsy syndrome	2.46e-05	0.00181	CbGpPWpGaD
Phenindamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6ST—epilepsy syndrome	2.46e-05	0.00181	CbGpPWpGaD
Phenindamine—Nortriptyline—CYP2D6—epilepsy syndrome	2.45e-05	0.00705	CrCbGaD
Phenindamine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—epilepsy syndrome	2.43e-05	0.00179	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—PRDM4—epilepsy syndrome	2.42e-05	0.00178	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—PRICKLE1—epilepsy syndrome	2.42e-05	0.00178	CbGpPWpGaD
Phenindamine—Amitriptyline—SLC6A4—epilepsy syndrome	2.42e-05	0.00696	CrCbGaD
Phenindamine—HRH1—GPCR downstream signaling—GRM8—epilepsy syndrome	2.41e-05	0.00177	CbGpPWpGaD
Phenindamine—HRH1—GPCR ligand binding—BDKRB2—epilepsy syndrome	2.36e-05	0.00174	CbGpPWpGaD
Phenindamine—HRH1—GPCR ligand binding—CXCL12—epilepsy syndrome	2.36e-05	0.00174	CbGpPWpGaD
Phenindamine—HRH1—Signaling by GPCR—ARHGEF9—epilepsy syndrome	2.36e-05	0.00173	CbGpPWpGaD
Phenindamine—HRH1—Signaling by GPCR—CCR8—epilepsy syndrome	2.36e-05	0.00173	CbGpPWpGaD
Phenindamine—HRH1—Signaling by GPCR—SSTR1—epilepsy syndrome	2.36e-05	0.00173	CbGpPWpGaD
Phenindamine—HRH1—Signaling by GPCR—NPY2R—epilepsy syndrome	2.36e-05	0.00173	CbGpPWpGaD
Phenindamine—HRH1—Signaling by GPCR—CCR9—epilepsy syndrome	2.36e-05	0.00173	CbGpPWpGaD
Phenindamine—HRH1—GPCR ligand binding—CNR1—epilepsy syndrome	2.32e-05	0.00171	CbGpPWpGaD
Phenindamine—HRH1—Signaling by GPCR—GRM4—epilepsy syndrome	2.31e-05	0.0017	CbGpPWpGaD
Phenindamine—HRH1—Signaling by GPCR—GRM3—epilepsy syndrome	2.31e-05	0.0017	CbGpPWpGaD
Phenindamine—HRH1—GPCR downstream signaling—OPRD1—epilepsy syndrome	2.3e-05	0.00169	CbGpPWpGaD
Phenindamine—Amitriptyline—CYP2C19—epilepsy syndrome	2.29e-05	0.0066	CrCbGaD
Phenindamine—HRH1—Signaling by GPCR—SSTR2—epilepsy syndrome	2.27e-05	0.00167	CbGpPWpGaD
Phenindamine—HRH1—GPCR ligand binding—HTR7—epilepsy syndrome	2.26e-05	0.00167	CbGpPWpGaD
Phenindamine—HRH1—GPCR downstream signaling—CCR7—epilepsy syndrome	2.21e-05	0.00162	CbGpPWpGaD
Phenindamine—HRH1—GPCR downstream signaling—PDYN—epilepsy syndrome	2.21e-05	0.00162	CbGpPWpGaD
Phenindamine—HRH1—GPCR downstream signaling—GRM1—epilepsy syndrome	2.21e-05	0.00162	CbGpPWpGaD
Phenindamine—HRH1—GPCR downstream signaling—CHRM1—epilepsy syndrome	2.21e-05	0.00162	CbGpPWpGaD
Phenindamine—HRH1—Signaling by GPCR—GRM8—epilepsy syndrome	2.19e-05	0.00161	CbGpPWpGaD
Phenindamine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR5—epilepsy syndrome	2.13e-05	0.00157	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—ACKR4—epilepsy syndrome	2.12e-05	0.00156	CbGpPWpGaD
Phenindamine—HRH1—Signaling by GPCR—GNAO1—epilepsy syndrome	2.09e-05	0.00154	CbGpPWpGaD
Phenindamine—HRH1—Signaling by GPCR—OPRD1—epilepsy syndrome	2.09e-05	0.00154	CbGpPWpGaD
Phenindamine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—epilepsy syndrome	2.08e-05	0.00153	CbGpPWpGaD
Phenindamine—HRH1—GPCR downstream signaling—GAL—epilepsy syndrome	2.07e-05	0.00153	CbGpPWpGaD
Phenindamine—HRH1—GPCR downstream signaling—GRM5—epilepsy syndrome	2.05e-05	0.00151	CbGpPWpGaD
Phenindamine—HRH1—GPCR downstream signaling—CHRM3—epilepsy syndrome	2.05e-05	0.00151	CbGpPWpGaD
Phenindamine—HRH1—Signaling by GPCR—GRM1—epilepsy syndrome	2e-05	0.00147	CbGpPWpGaD
Phenindamine—HRH1—Signaling by GPCR—PDYN—epilepsy syndrome	2e-05	0.00147	CbGpPWpGaD
Phenindamine—HRH1—Signaling by GPCR—CHRM1—epilepsy syndrome	2e-05	0.00147	CbGpPWpGaD
Phenindamine—HRH1—Signaling by GPCR—CCR7—epilepsy syndrome	2e-05	0.00147	CbGpPWpGaD
Phenindamine—HRH1—Class A/1 (Rhodopsin-like receptors)—AGT—epilepsy syndrome	1.98e-05	0.00145	CbGpPWpGaD
Phenindamine—HRH1—GPCR downstream signaling—CHRM2—epilepsy syndrome	1.93e-05	0.00142	CbGpPWpGaD
Phenindamine—HRH1—GPCR downstream signaling—BDKRB1—epilepsy syndrome	1.93e-05	0.00142	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—SSTR4—epilepsy syndrome	1.92e-05	0.00141	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—SSTR5—epilepsy syndrome	1.92e-05	0.00141	CbGpPWpGaD
Phenindamine—HRH1—GPCR ligand binding—AVP—epilepsy syndrome	1.91e-05	0.0014	CbGpPWpGaD
Phenindamine—HRH1—Signaling by GPCR—GAL—epilepsy syndrome	1.88e-05	0.00139	CbGpPWpGaD
Phenindamine—HRH1—GPCR downstream signaling—GABBR1—epilepsy syndrome	1.88e-05	0.00138	CbGpPWpGaD
Phenindamine—HRH1—Signaling by GPCR—GRM5—epilepsy syndrome	1.86e-05	0.00137	CbGpPWpGaD
Phenindamine—HRH1—Signaling by GPCR—CHRM3—epilepsy syndrome	1.86e-05	0.00137	CbGpPWpGaD
Phenindamine—Amitriptyline—HTR2A—epilepsy syndrome	1.86e-05	0.00535	CrCbGaD
Phenindamine—HRH1—Signaling Pathways—CCR10—epilepsy syndrome	1.84e-05	0.00135	CbGpPWpGaD
Phenindamine—Nortriptyline—ALB—epilepsy syndrome	1.83e-05	0.00528	CrCbGaD
Phenindamine—HRH1—GPCR downstream signaling—HRH3—epilepsy syndrome	1.8e-05	0.00132	CbGpPWpGaD
Phenindamine—HRH1—Signaling by GPCR—CX3CR1—epilepsy syndrome	1.79e-05	0.00131	CbGpPWpGaD
Phenindamine—HRH1—GPCR downstream signaling—OPRM1—epilepsy syndrome	1.77e-05	0.0013	CbGpPWpGaD
Phenindamine—HRH1—Signaling by GPCR—BDKRB1—epilepsy syndrome	1.75e-05	0.00129	CbGpPWpGaD
Phenindamine—HRH1—Signaling by GPCR—CHRM2—epilepsy syndrome	1.75e-05	0.00129	CbGpPWpGaD
Phenindamine—HRH1—Signaling by GPCR—CX3CL1—epilepsy syndrome	1.75e-05	0.00129	CbGpPWpGaD
Phenindamine—HRH1—Signaling by GPCR—GABBR1—epilepsy syndrome	1.7e-05	0.00125	CbGpPWpGaD
Phenindamine—Amitriptyline—CYP2D6—epilepsy syndrome	1.7e-05	0.00489	CrCbGaD
Phenindamine—HRH1—GPCR downstream signaling—CCR3—epilepsy syndrome	1.67e-05	0.00123	CbGpPWpGaD
Phenindamine—HRH1—Class A/1 (Rhodopsin-like receptors)—POMC—epilepsy syndrome	1.66e-05	0.00122	CbGpPWpGaD
Phenindamine—HRH1—Signaling by GPCR—HRH3—epilepsy syndrome	1.63e-05	0.0012	CbGpPWpGaD
Phenindamine—HRH1—GPCR downstream signaling—NPY—epilepsy syndrome	1.63e-05	0.0012	CbGpPWpGaD
Phenindamine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL2—epilepsy syndrome	1.63e-05	0.0012	CbGpPWpGaD
Phenindamine—HRH1—GPCR ligand binding—CCR5—epilepsy syndrome	1.62e-05	0.00119	CbGpPWpGaD
Phenindamine—HRH1—Signaling by GPCR—OPRM1—epilepsy syndrome	1.61e-05	0.00118	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—GRM2—epilepsy syndrome	1.61e-05	0.00118	CbGpPWpGaD
Phenindamine—HRH1—GPCR ligand binding—HTR2A—epilepsy syndrome	1.59e-05	0.00117	CbGpPWpGaD
Phenindamine—HRH1—GPCR downstream signaling—CXCL2—epilepsy syndrome	1.57e-05	0.00116	CbGpPWpGaD
Phenindamine—HRH1—GPCR downstream signaling—CRH—epilepsy syndrome	1.57e-05	0.00116	CbGpPWpGaD
Phenindamine—HRH1—GPCR downstream signaling—OXT—epilepsy syndrome	1.57e-05	0.00116	CbGpPWpGaD
Phenindamine—HRH1—Signaling by GPCR—CCR3—epilepsy syndrome	1.52e-05	0.00112	CbGpPWpGaD
Phenindamine—HRH1—GPCR ligand binding—AGT—epilepsy syndrome	1.51e-05	0.00111	CbGpPWpGaD
Phenindamine—HRH1—Signaling by GPCR—NPY—epilepsy syndrome	1.48e-05	0.00109	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—SSTR3—epilepsy syndrome	1.45e-05	0.00107	CbGpPWpGaD
Phenindamine—HRH1—Signaling by GPCR—OXT—epilepsy syndrome	1.43e-05	0.00105	CbGpPWpGaD
Phenindamine—HRH1—Signaling by GPCR—CRH—epilepsy syndrome	1.43e-05	0.00105	CbGpPWpGaD
Phenindamine—HRH1—Signaling by GPCR—CXCL2—epilepsy syndrome	1.43e-05	0.00105	CbGpPWpGaD
Phenindamine—HRH1—Signaling by GPCR—CCL3—epilepsy syndrome	1.43e-05	0.00105	CbGpPWpGaD
Phenindamine—HRH1—GPCR downstream signaling—SST—epilepsy syndrome	1.42e-05	0.00105	CbGpPWpGaD
Phenindamine—HRH1—GPCR downstream signaling—CCR2—epilepsy syndrome	1.42e-05	0.00105	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—ST3GAL3—epilepsy syndrome	1.42e-05	0.00105	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—ARHGEF9—epilepsy syndrome	1.39e-05	0.00102	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—CCR9—epilepsy syndrome	1.39e-05	0.00102	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—NPY2R—epilepsy syndrome	1.39e-05	0.00102	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—CCR8—epilepsy syndrome	1.39e-05	0.00102	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—SSTR1—epilepsy syndrome	1.39e-05	0.00102	CbGpPWpGaD
Phenindamine—HRH1—GPCR downstream signaling—ADRA2A—epilepsy syndrome	1.39e-05	0.00102	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—GRM3—epilepsy syndrome	1.36e-05	0.001	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—GRM4—epilepsy syndrome	1.36e-05	0.001	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—DUSP4—epilepsy syndrome	1.34e-05	0.000986	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—SSTR2—epilepsy syndrome	1.34e-05	0.000986	CbGpPWpGaD
Phenindamine—HRH1—GPCR downstream signaling—CXCL12—epilepsy syndrome	1.34e-05	0.000983	CbGpPWpGaD
Phenindamine—HRH1—GPCR downstream signaling—BDKRB2—epilepsy syndrome	1.34e-05	0.000983	CbGpPWpGaD
Phenindamine—HRH1—GPCR downstream signaling—CNR1—epilepsy syndrome	1.31e-05	0.000965	CbGpPWpGaD
Phenindamine—HRH1—GPCR downstream signaling—PLCB1—epilepsy syndrome	1.31e-05	0.000962	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—GRM8—epilepsy syndrome	1.29e-05	0.000952	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—PGF—epilepsy syndrome	1.29e-05	0.000952	CbGpPWpGaD
Phenindamine—HRH1—Signaling by GPCR—CCR2—epilepsy syndrome	1.29e-05	0.00095	CbGpPWpGaD
Phenindamine—HRH1—Signaling by GPCR—SST—epilepsy syndrome	1.29e-05	0.00095	CbGpPWpGaD
Phenindamine—HRH1—GPCR downstream signaling—HTR7—epilepsy syndrome	1.28e-05	0.000942	CbGpPWpGaD
Phenindamine—Amitriptyline—ALB—epilepsy syndrome	1.27e-05	0.00366	CrCbGaD
Phenindamine—HRH1—GPCR ligand binding—POMC—epilepsy syndrome	1.27e-05	0.000932	CbGpPWpGaD
Phenindamine—HRH1—Signaling by GPCR—ADRA2A—epilepsy syndrome	1.26e-05	0.000929	CbGpPWpGaD
Phenindamine—HRH1—GPCR ligand binding—CCL2—epilepsy syndrome	1.24e-05	0.000912	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—GNAO1—epilepsy syndrome	1.23e-05	0.000908	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—OPRD1—epilepsy syndrome	1.23e-05	0.000908	CbGpPWpGaD
Phenindamine—HRH1—GPCR downstream signaling—AKT3—epilepsy syndrome	1.22e-05	0.000897	CbGpPWpGaD
Phenindamine—HRH1—Signaling by GPCR—CXCL12—epilepsy syndrome	1.21e-05	0.000893	CbGpPWpGaD
Phenindamine—HRH1—Signaling by GPCR—BDKRB2—epilepsy syndrome	1.21e-05	0.000893	CbGpPWpGaD
Phenindamine—Amitriptyline—ABCB1—epilepsy syndrome	1.21e-05	0.0035	CrCbGaD
Phenindamine—HRH1—Signaling by GPCR—CNR1—epilepsy syndrome	1.19e-05	0.000876	CbGpPWpGaD
Phenindamine—HRH1—Signaling by GPCR—PLCB1—epilepsy syndrome	1.19e-05	0.000873	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—PDYN—epilepsy syndrome	1.18e-05	0.000871	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—CHRM1—epilepsy syndrome	1.18e-05	0.000871	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—CCR7—epilepsy syndrome	1.18e-05	0.000871	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—GRM1—epilepsy syndrome	1.18e-05	0.000871	CbGpPWpGaD
Phenindamine—HRH1—Signaling by GPCR—HTR7—epilepsy syndrome	1.16e-05	0.000855	CbGpPWpGaD
Phenindamine—HRH1—Signaling by GPCR—HBEGF—epilepsy syndrome	1.13e-05	0.00083	CbGpPWpGaD
Phenindamine—HRH1—GPCR downstream signaling—CDC42—epilepsy syndrome	1.11e-05	0.000819	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—GFAP—epilepsy syndrome	1.11e-05	0.000819	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—GAL—epilepsy syndrome	1.11e-05	0.000819	CbGpPWpGaD
Phenindamine—HRH1—Signaling by GPCR—AKT3—epilepsy syndrome	1.11e-05	0.000815	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—GRM5—epilepsy syndrome	1.1e-05	0.000809	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—CHRM3—epilepsy syndrome	1.1e-05	0.000809	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—CASP2—epilepsy syndrome	1.1e-05	0.000809	CbGpPWpGaD
Phenindamine—HRH1—GPCR downstream signaling—AVP—epilepsy syndrome	1.08e-05	0.000793	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—CX3CR1—epilepsy syndrome	1.05e-05	0.000776	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—CHRM2—epilepsy syndrome	1.03e-05	0.000761	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—CX3CL1—epilepsy syndrome	1.03e-05	0.000761	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—BDKRB1—epilepsy syndrome	1.03e-05	0.000761	CbGpPWpGaD
Phenindamine—HRH1—Signaling by GPCR—CDC42—epilepsy syndrome	1.01e-05	0.000743	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—GABBR1—epilepsy syndrome	1.01e-05	0.00074	CbGpPWpGaD
Phenindamine—HRH1—Signaling by GPCR—AVP—epilepsy syndrome	9.78e-06	0.00072	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—HRH3—epilepsy syndrome	9.65e-06	0.00071	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—OPRM1—epilepsy syndrome	9.5e-06	0.000699	CbGpPWpGaD
Phenindamine—HRH1—GPCR downstream signaling—CCR5—epilepsy syndrome	9.16e-06	0.000674	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—CCR3—epilepsy syndrome	8.97e-06	0.00066	CbGpPWpGaD
Phenindamine—HRH1—GPCR downstream signaling—HTR2A—epilepsy syndrome	8.96e-06	0.000659	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—NPY—epilepsy syndrome	8.74e-06	0.000643	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—ATP2A2—epilepsy syndrome	8.74e-06	0.000643	CbGpPWpGaD
Phenindamine—HRH1—GPCR downstream signaling—AGT—epilepsy syndrome	8.51e-06	0.000626	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—HSPB1—epilepsy syndrome	8.43e-06	0.00062	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—CRH—epilepsy syndrome	8.43e-06	0.00062	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—OXT—epilepsy syndrome	8.43e-06	0.00062	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—CXCL2—epilepsy syndrome	8.43e-06	0.00062	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—CCL3—epilepsy syndrome	8.43e-06	0.00062	CbGpPWpGaD
Phenindamine—HRH1—Signaling by GPCR—CCR5—epilepsy syndrome	8.32e-06	0.000612	CbGpPWpGaD
Phenindamine—HRH1—Signaling by GPCR—HTR2A—epilepsy syndrome	8.14e-06	0.000599	CbGpPWpGaD
Phenindamine—HRH1—GPCR downstream signaling—PRKCB—epilepsy syndrome	7.86e-06	0.000578	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—TSC1—epilepsy syndrome	7.84e-06	0.000577	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—PTK2B—epilepsy syndrome	7.84e-06	0.000577	CbGpPWpGaD
Phenindamine—HRH1—Signaling by GPCR—AGT—epilepsy syndrome	7.72e-06	0.000568	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—SST—epilepsy syndrome	7.63e-06	0.000561	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—CCR2—epilepsy syndrome	7.63e-06	0.000561	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—NTRK2—epilepsy syndrome	7.63e-06	0.000561	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—DUSP6—epilepsy syndrome	7.56e-06	0.000556	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—ADRA2A—epilepsy syndrome	7.46e-06	0.000549	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—PLAT—epilepsy syndrome	7.43e-06	0.000547	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—CXCL12—epilepsy syndrome	7.17e-06	0.000527	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—BDKRB2—epilepsy syndrome	7.17e-06	0.000527	CbGpPWpGaD
Phenindamine—HRH1—GPCR downstream signaling—POMC—epilepsy syndrome	7.16e-06	0.000527	CbGpPWpGaD
Phenindamine—HRH1—Signaling by GPCR—PRKCB—epilepsy syndrome	7.14e-06	0.000525	CbGpPWpGaD
Phenindamine—HRH1—Signaling by GPCR—IL6ST—epilepsy syndrome	7.11e-06	0.000523	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—JUNB—epilepsy syndrome	7.04e-06	0.000518	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—CNR1—epilepsy syndrome	7.04e-06	0.000518	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—PLCB1—epilepsy syndrome	7.01e-06	0.000516	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—HTR7—epilepsy syndrome	6.87e-06	0.000505	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—HBEGF—epilepsy syndrome	6.67e-06	0.00049	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—AKT3—epilepsy syndrome	6.54e-06	0.000481	CbGpPWpGaD
Phenindamine—HRH1—Signaling by GPCR—POMC—epilepsy syndrome	6.5e-06	0.000478	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—ADAM10—epilepsy syndrome	6.39e-06	0.00047	CbGpPWpGaD
Phenindamine—HRH1—Signaling by GPCR—CCL2—epilepsy syndrome	6.36e-06	0.000468	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—S100B—epilepsy syndrome	6.04e-06	0.000445	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—SOCS3—epilepsy syndrome	5.98e-06	0.00044	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—CDC42—epilepsy syndrome	5.97e-06	0.000439	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—AVP—epilepsy syndrome	5.78e-06	0.000425	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—HES1—epilepsy syndrome	5.46e-06	0.000402	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—FYN—epilepsy syndrome	5.31e-06	0.000391	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—H2AFX—epilepsy syndrome	5.29e-06	0.00039	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—MEF2C—epilepsy syndrome	5.29e-06	0.000389	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—YWHAZ—epilepsy syndrome	5.11e-06	0.000376	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—NGF—epilepsy syndrome	5.05e-06	0.000372	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—CCR5—epilepsy syndrome	4.91e-06	0.000361	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—HTR2A—epilepsy syndrome	4.81e-06	0.000354	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—TSC2—epilepsy syndrome	4.57e-06	0.000336	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—AGT—epilepsy syndrome	4.56e-06	0.000336	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—APOE—epilepsy syndrome	4.47e-06	0.000329	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—KDR—epilepsy syndrome	4.38e-06	0.000322	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—PRKCB—epilepsy syndrome	4.22e-06	0.00031	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—IL6ST—epilepsy syndrome	4.2e-06	0.000309	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—POMC—epilepsy syndrome	3.84e-06	0.000283	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—CCL2—epilepsy syndrome	3.76e-06	0.000276	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—FGF2—epilepsy syndrome	3.4e-06	0.00025	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—RELA—epilepsy syndrome	3.15e-06	0.000232	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—MTOR—epilepsy syndrome	3.09e-06	0.000227	CbGpPWpGaD
Phenindamine—HRH1—GPCR downstream signaling—AKT1—epilepsy syndrome	2.87e-06	0.000211	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—CASP3—epilepsy syndrome	2.84e-06	0.000209	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—JUN—epilepsy syndrome	2.76e-06	0.000203	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—MMP9—epilepsy syndrome	2.69e-06	0.000198	CbGpPWpGaD
Phenindamine—HRH1—Signaling by GPCR—AKT1—epilepsy syndrome	2.61e-06	0.000192	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—SRC—epilepsy syndrome	2.48e-06	0.000182	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—VEGFA—epilepsy syndrome	2.41e-06	0.000178	CbGpPWpGaD
Phenindamine—HRH1—Signaling Pathways—AKT1—epilepsy syndrome	1.54e-06	0.000113	CbGpPWpGaD
